Site Location: Home > Client Services > Planning Services > Life Sciences
Dedicated Planning for capital raising
Fundraising for developing life sciences and medical technology companies has become increasingly difficult in the current financial climate.
To increase the chances of success, financing-seeking companies should exploit the contribution that professional business planning can deliver in presenting their plan to investors and VC firms.
Companies should use high-quality planning to quantity the expected returns and address the relationship between risk and returns in the presentation of their company to investors. A powerful strategic plan is an important asset which makes a company more financeable.
When your company is seeking to raise capital, Expantium can assist in the process by quickly providing high-quality financial business planning, based on the revenue-generating potential of your company’s services, technology, R&D projects, collaborative programmes and proposed strategy. We can help to enhance existing financial planning or we can provide you with a new, high-value Financial Business Plan to support the funding initiative. We provide also help with preparing the presentation to investors, including the company’s achievements to date, a full quantification of its key risks and financial returns, the company’s future development plans, expected competitive position, revenue projections and activity timelines.
Addressing in-depth questions from investors
Potential investors typically raise questions related to the market (e.g. size and segmentation; market trends; entry barriers) and prospects for the company (e.g. value of current alliances; potential upside from the current portfolio; key risks; critical success factors; steps and timing for adding value; exit opportunities). In order for the company to successfully raise its required capital from investors, Expantium can provide a clarification on your behalf of the critical success factors, returns and key risks going forward, to assist your company with the fundraising initiative and increase the change of successful obtainment of investor capital.
Second opinion on valuation outcomes
Sometimes a Venture Capital firm is willing to fund a venture, but the capital-seeking company feels that the suggested Valuation is too low to fairly represent his company's assets and activities. As VC firms invest in a multitude of different ventures, often their financial evaluation framework follows a general methodology that insufficiently accounts for specific industry factors, thereby potentially misreading the revenue generating capacity of your proposal. VC firms also work under time pressure, where analysts have to deliver valuations of multiple companies in a short amount of time. In those cases, Expantium can provide a detailed, fully industry-specific assessment of your company’s revenue generating potential, and support you during the fundraising process to clarify the value of your initiative to investors.
<< Back to the Overview
To find out more about Expantium's work in this solution area or how we can support the growth objective of your organisation, please contact lifesciences@expantium.com, call us or complete the contact form.
